Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis

Glioblastoma (GBM) remains uniformly lethal, and despite a large accumulation of immune cells in the microenvironment, there is limited antitumor immune response. To overcome these challenges, a comprehensive understanding of GBM systemic immune response during disease progression is required. Here,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:JCI Insight
Asıl Yazarlar: Alban, Tyler J., Alvarado, Alvaro G., Sorensen, Mia D., Bayik, Defne, Volovetz, Josephine, Serbinowski, Emily, Mulkearns-Hubert, Erin E., Sinyuk, Maksim, Hale, James S., Onzi, Giovana R., McGraw, Mary, Huang, Pengjing, Grabowski, Matthew M., Wathen, Connor A., Ahluwalia, Manmeet S., Radivoyevitch, Tomas, Kornblum, Harley I., Kristensen, Bjarne W., Vogelbaum, Michael A., Lathia, Justin D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Clinical Investigation 2018
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6238746/
https://ncbi.nlm.nih.gov/pubmed/30385717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.122264
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller